Drug resistance profile among multi-drug resistant tuberculosis patients at diagnosis and correlation with history of anti-tubercular treatment in a tertiary care center

Simple item page
dc.contributor.authorKumar, Rahulen_US
dc.contributor.authorGarg, Rajiven_US
dc.contributor.authorKshetrimayum, Silpaen_US
dc.contributor.authorJain, Amitaen_US
dc.date.accessioned2020-04-09T07:42:50Z
dc.date.available2020-04-09T07:42:50Z
dc.date.issued2019-11
dc.description.abstractBackground: Drug Resistant Tuberculosis (DR-TB) is a major threat to the realization of the goal of a TB free world in the near future. It is important to study the reasons for the increasing number of such cases so that effective action can be taken to control this growing epidemic.Methods: Sputum from 36 patients diagnosed with acquired pulmonary Multidrug Resistant Tuberculosis (MDR-TB) were subjected to first- and second-line Drug Sensitivity Testing (DST) after liquid culture in mycobacterium growth Indicator Tube (MGIT). Primary MDR-TB cases were excluded. The relation of the drug sensitivity profile with the history of prior treatment taken was statistically analysed.Results: Majority of the patients had received appropriate treatment, and most had adhered to prescribed treatment. Among the 36 patients, 24(66.7%) were found to be Pre-Extensively Drug Resistant (Pre-XDR-TB) and 4(11.1%) were extensively drug resistant XDR-TB cases. Inappropriate prescription of fluoroquinolone (FQ) was found to be most common. Prior intake of any drug was not found to significantly affect subsequent resistance to that drug.Conclusions: Fluoroquinolone resistance is quite common in patients with DR-TB (66.7%). This study did not find the prior use of FQ or any other drug to significantly affect subsequent resistance to the drug. Primary drug resistance is thus a major concern. 11.1% patients were found to be XDR-TB cases. Hence DST for first- and second-line drugs should be done at the time of diagnosis to avoid failure of treatment with a predesigned regimen.en_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, All India Institute of Medical Sciences, Patna, Bihar, Indiaen_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Respiratory Medicine, Regional Institute of Medical Sciences, Imphal, Manipur, Indiaen_US
dc.identifier.affiliationsDepartment of Microbiology, King George’s Medical University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.citationKumar Rahul, Garg Rajiv, Kshetrimayum Silpa, Jain Amita. Drug resistance profile among multi-drug resistant tuberculosis patients at diagnosis and correlation with history of anti-tubercular treatment in a tertiary care center. International Journal of Advances in Medicine. 2019 Nov; 6(6): 1918-1923en_US
dc.identifier.issn2349-3925
dc.identifier.issn2349-3933
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/194427
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber6en_US
dc.relation.volume6en_US
dc.source.urihttps://dx.doi.org/10.18203/2349-3933.ijam20195251en_US
dc.subjectDrug resistant tuberculosisen_US
dc.subjectDrug sensitivity testingen_US
dc.subjectExtensively drug resistanten_US
dc.subjectFluoroquinoloneen_US
dc.subjectMultidrug resistanten_US
dc.subjectMultidrug resistanten_US
dc.titleDrug resistance profile among multi-drug resistant tuberculosis patients at diagnosis and correlation with history of anti-tubercular treatment in a tertiary care centeren_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijam2019v6n6p1918.pdf
Size:
212.66 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Advances in Medicine